论文部分内容阅读
我院于1986年6月开始,将尿激酶应用于青光眼手术27例33眼,随访半年以上者10例12眼,现将结果报导如下。随访半年以上10例开角型青光眼患者,包括曾行滤过手术失败者3例5眼。年龄17~34岁,共8例8眼,其中1例曾经手术失败,术前平均眼压为30.32mmHg。在手术完毕后,立刻注射尿激酶,以后每日注射1次。除2眼在手术次日发现前房出血,未注射外,其余均注射3~7次。每次将尿激酶3,000国际单位溶解于0.3ml 蒸溜水中,注射于下穹窿部。随访时间最长18个月,最短6个月,平均7.1个月。随访时,10例12眼眼压正常,眼压平均为12.05mmHg。其中只有1只眼仍用噻吗心胺1日2次滴
Our hospital began in June 1986, urokinase used in 27 cases of glaucoma surgery 33 eyes, followed up for more than six months in 10 cases 12 eyes, the results reported below. Follow-up more than six months 10 cases of open-angle glaucoma patients, including those who have failed to filter surgery in 3 cases 5 eyes. Aged 17 to 34 years old, a total of 8 cases 8 eyes, of which 1 case had failed surgery, the average preoperative intraocular pressure was 30.32mmHg. Immediately after surgery, inject urokinase and inject it once daily. Except for 2 eyes, the anterior chamber bleeding was found on the next day of operation, and the others were injected 3 to 7 times without injection. Each time urokinase 3,000 international units dissolved in 0.3ml distilled water, injected into the lower fornix. The longest follow-up of 18 months, the shortest 6 months, an average of 7.1 months. At follow-up, 10 eyes of 12 had normal intraocular pressure and an average intraocular pressure of 12.05 mmHg. Only one of them still used timoxema 2 drops on the 1st